Stryker Orthopaedics
Country not established
- Devices
- 24
- FDA recalls
- 66 ongoing
At a glance
Market reach
- United States
- FDA recalls
What Stryker Orthopaedics makes
Stryker Orthopaedics manufactures orthopaedic implants for hip and knee replacements, including femoral stems, acetabular shells, knee components, and patellar replacements. Products include modular hip systems like the Insignia and Exeter femoral stems, posterior-stabilized knee implants such as the Triathlon system, and metal-backed patellas. Specialized tools like the Exeter Centralizer and femoral heads for hip systems are also part of the portfolio.
These devices are classified as Class II under FDA regulations and are supported by 510(k) clearances. The company’s products are listed in the FDA’s 510(k) database. Stryker Orthopaedics is headquartered in the United States.
Catalogue
Search and filter all 24 devicesFDA recalls
FDA recall records list 6 recalls initiated by Stryker Orthopaedics, initiated on 2024-04-15. By recorded status: 6 ongoing. The reasons filed fall into these groups: software or firmware. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.
Recalls initiated per year
- 2017 0
- 2018 0
- 2019 0
- 2020 0
- 2021 0
- 2022 0
- 2023 0
- 2024 6
- 2025 0
- 2026 0
2024
- 15 Apr 2024 Z-1910-2024 Class II Ongoing Application software intended to be deployed on Mako 3.0, part number 209999, and Mako 3.1, part number 219999, observed an increase in the Software Error #3 (SE3) error code when a Mako System shutdown or a Mako System restart is not performed prior to
switching between applications (i.e. TKA to THA), resulting in delay in treatment
Full distribution text
- 15 Apr 2024 Z-1911-2024 Class II Ongoing Application software intended to be deployed on Mako 3.0, part number 209999, and Mako 3.1, part number 219999, observed an increase in the Software Error #3 (SE3) error code when a Mako System shutdown or a Mako System restart is not performed prior to
switching between applications (i.e. TKA to THA), resulting in delay in treatment
Full distribution text
- 15 Apr 2024 Z-1912-2024 Class II Ongoing Application software intended to be deployed on Mako 3.0, part number 209999, and Mako 3.1, part number 219999, observed an increase in the Software Error #3 (SE3) error code when a Mako System shutdown or a Mako System restart is not performed prior to
switching between applications (i.e. TKA to THA), resulting in delay in treatment
Full distribution text
- 15 Apr 2024 Z-1913-2024 Class II Ongoing Application software intended to be deployed on Mako 3.0, part number 209999, and Mako 3.1, part number 219999, observed an increase in the Software Error #3 (SE3) error code when a Mako System shutdown or a Mako System restart is not performed prior to
switching between applications (i.e. TKA to THA), resulting in delay in treatment
Full distribution text
- 15 Apr 2024 Z-1914-2024 Class II Ongoing Application software intended to be deployed on Mako 3.0, part number 209999, and Mako 3.1, part number 219999, observed an increase in the Software Error #3 (SE3) error code when a Mako System shutdown or a Mako System restart is not performed prior to
switching between applications (i.e. TKA to THA), resulting in delay in treatment
Full distribution text
- 15 Apr 2024 Z-1915-2024 Class II Ongoing Application software intended to be deployed on Mako 3.0, part number 209999, and Mako 3.1, part number 219999, observed an increase in the Software Error #3 (SE3) error code when a Mako System shutdown or a Mako System restart is not performed prior to
switching between applications (i.e. TKA to THA), resulting in delay in treatment
Full distribution text
- 15 Apr 2024 Z-1910-2024 Class II Ongoing Application software intended to be deployed on Mako 3.0, part number 209999, and Mako 3.1, part number 219999, observed an increase in the Software Error #3 (SE3) error code when a Mako System shutdown or a Mako System restart is not performed prior to
switching between applications (i.e. TKA to THA), resulting in delay in treatment
Frequently asked questions
How many devices does Stryker Orthopaedics have in the registry?
The registry currently lists 24 devices for Stryker Orthopaedics. Devices recorded under merged duplicate company entries are counted once.
Which registries list Stryker Orthopaedics's devices?
Among its 24 most recently registered devices, Stryker Orthopaedics has devices listed in FDA 510(k) (24 devices).
What risk classes do Stryker Orthopaedics's devices fall under?
Among its 24 most recently registered devices, the classes recorded for Stryker Orthopaedics's devices are Class II. Each device page shows its own class and authorisation.
Are there FDA recall records for Stryker Orthopaedics?
FDA recall records list 6 recalls initiated by Stryker Orthopaedics, the most recent initiated on 15 Apr 2024. 6 of them are recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What are the newest devices from Stryker Orthopaedics in the registry?
The most recently registered devices listed for Stryker Orthopaedics include SIMPLEX P BONE CEMENT, SHORT CITATION FEMORAL STEM, Insignia Hip Stem and EXETER Centralizer, EXETER 2.5mm Plug.